Product Information
MECLIZINE 12.5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0309 per EA under NDC 57237033301. Its NADAC has been published 54 times since Jun 18, 2025.
The High Outlier badge above means this manufacturer's average price in the MECLIZINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237033301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MECLIZINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M009.50On Market Since
7/22/2024
Pharmacological Classes
Price Statistics
The NADAC for MECLIZINE 12.5 MG TABLET has been published 54 times since Jun 18, 2025, and over the history we have for it it has risen 11.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0309 per EA |
|---|---|
| All-time high | $0.0357 (Oct 15, 2025) |
| All-time low | $0.0277 (Jun 18, 2025) |
| 52-week high | $0.0357 |
| 52-week low | $0.0277 |
| Median price | $0.0308 |
| Average price | $0.0312 |
| Largest weekly change | +17.9% (Jul 23, 2025) |
| Weeks tracked | 54 |
| Tracking since | Jun 18, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MECLIZINE 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MECLIZINE 12.5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0309 per EA (NDC 57237033301), effective Jun 24, 2026.
How has the price of MECLIZINE 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MECLIZINE 12.5 MG TABLET has risen 11.6%. It has been tracked across 54 weekly CMS publications since Jun 18, 2025.
What are the highest and lowest recorded NADAC prices for MECLIZINE 12.5 MG TABLET?
Since Jun 18, 2025, the NADAC for MECLIZINE 12.5 MG TABLET has ranged from a low of $0.0277 (Jun 18, 2025) to a high of $0.0357 (Oct 15, 2025), with a median of $0.0308 per EA.
Are there cheaper alternatives to MECLIZINE 12.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as MECLIZINE 12.5 MG TABLET, but none are currently priced below it.
Who manufactures MECLIZINE 12.5 MG TABLET?
MECLIZINE 12.5 MG TABLET (NDC 57237033301) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification